US2007104858A1PendingUtilityA1

Process for extraction of beta-glucan from cereals and products obtained therefrom

Assignee: ROXDALE FOODS LTD A NEW ZEALANPriority: Feb 7, 2000Filed: Nov 21, 2006Published: May 10, 2007
Est. expiryFeb 7, 2020(expired)· nominal 20-yr term from priority
Inventors:Keith Morgan
A23L 33/21C08B 30/10A23L 7/115A61K 31/716C08B 37/0024
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for lowering serum cholesterol levels, healing a wound, modulating glycaemic response, alleviating constipation, or stimulating the immune system. The method includes administering to a subject in need β-glucan obtained by forming flour from the cereal grain; mixing the flour with water at a temperature in the range of 25-65° C. to form a slurry of an aqueous solution of β-glucan and a solid residue; separating the aqueous solution from the solid residue; removing water from the aqueous solution by evaporating or ultrafiltration or combinations thereof to give a concentrated aqueous solution of β-glucan; and forming a β-glucan gel from the concentrated aqueous solution of β-glucan.

Claims

exact text as granted — not AI-modified
1 - 41 . (canceled)  
   
   
       42 . A method for lowering serum cholesterol levels in an animal including administering to the animal β-glucan obtained by a process including: 
 forming flour from the cereal grain;    mixing the flour with water at a temperature in the range of 25-65° C. to form a slurry of an aqueous solution of β-glucan and a solid residue,    separating the aqueous solution from the solid residue;    removing water from the aqueous solution by evaporating or ultrafiltration or combinations thereof to give a concentrated aqueous solution of β-glucan; and    forming a β-glucan gel from the concentrated aqueous solution of β-glucan.    
   
   
       43 . A method for healing a wound in an animal including administering to the animal β-glucan obtained by a process including: 
 forming flour from the cereal grain;    mixing the flour with water at a temperature in the range of 25-65° C. to form a slurry of an aqueous solution of β-glucan and a solid residue;    separating the aqueous solution from the solid residue;    removing water from the aqueous solution by evaporating or ultrafiltration or combinations thereof to give a concentrated aqueous solution of β-glucan; and    forming a β-glucan gel from the concentrated aqueous solution of β-glucan.    
   
   
       44 . A method for modulating glycaemic response in an animal including administering to the animal β-glucan obtained by a process including: 
 forming flour from the cereal grain;    mixing the flour with water at a temperature in the range of 25-65° C. to form a slurry of an aqueous solution of β-glucan and a solid residue;    separating the aqueous solution from the solid residue;    removing water from the aqueous solution by evaporating or ultrafiltration or combinations thereof to give a concentrated aqueous solution of β-glucan; and    forming a β-glucan gel from the concentrated aqueous solution of β-glucan.    
   
   
       45 . A method for alleviating constipation in an animal including administering to the animal β-glucan obtained by a process including: 
 forming flour from the cereal grain;    mixing the flour with water at a temperature in the range of 25-65° C. to form a slurry of an aqueous solution of β-glucan and a solid residue;    separating the aqueous solution from the solid residue;    removing water from the aqueous solution by evaporating or ultrafiltration or combinations thereof to give a concentrated aqueous solution of β-glucan; and    forming a β-glucan gel from the concentrated aqueous solution of β-glucan.    
   
   
       46 . A method for stimulating the immune system in an animal including administering to the animal β-glucan obtained by the process of a process including: 
 forming flour from the cereal grain;    mixing the flour with water at a temperature in the range of 25-65° C. to form a slurry of an aqueous solution of β-glucan and a solid residue;    separating the aqueous solution from the solid residue;    removing water from the aqueous solution by evaporating or ultrafiltration or combinations thereof to give a concentrated aqueous solution of β-glucan; and    forming a β-glucan gel from the concentrated aqueous solution of β-glucan.

Join the waitlist — get patent alerts

Track US2007104858A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.